Livestock Market Opportunity D2Dx immunity testing has already launched for cattle immune health, signaling a strong entry point in the livestock market. Opportunities exist to partner with dairies, feedlots, veterinarians, and animal health distributors to scale adoption and expand to related species.

Human Health Potential The D2Dx platform targets immune status in both animals and humans, offering avenues to pursue human clinical immunology settings, with emphasis on validation, regulatory steps, and cross-selling from existing animal health channels.

IP as Moat Multiple granted patents and pending applications create a defensible technology moat, enabling licensing, exclusive distribution, and collaborations with larger biotech players or research organizations.

Scale Through Partnerships A small team and mid-scale revenue suggest the business should pursue channel partnerships, contract manufacturing, and CRO/CMO collaborations to accelerate market reach and ensure scalable production.

Go To Market Leverage veterinary labs, animal clinics, and farm networks as primary channels; explore collaborations with established animal health companies to accelerate distribution and gather real-world usage data for expansion.